What is in the future for T-cell lymphoma?
Identifying human cancers to target with BCL-2 inhibition
Developments in therapies for AML - chemotherapy, targeted therapy and immunotherapy
Hagop M. Kantarjian
The importance of diagnosing DLBCL on a molecular level and how it will improve treatment